Abstract Objectives: To study contemporary treatment and outcome of abdominal aortic aneurysm (AAA) repair in nine countries. Design and methods: Data on primary AAA repairs 2005e2009 were amalgamated from national and regional vascular registries in Australia, Denmark, Finland, Hungary, Italy, Norway, Sweden, Switzerland and the UK. Primary outcome was in-hospital or 30-day mortality. Multivariate logistic regression was used to assess case-mix. Results: 31,427 intact AAA repairs were identified, mean age 72.6 years (95% CI 72.5e72.7). The rate of octogenarians and use of endovascular repair (EVAR) increased over time (p < 0.001). EVAR varied between countries from 14.7% (Finland) to 56.0% (Australia). Overall perioperative mortality after intact AAA repair was 2.8% (2.6e3.0) and was stable over time. The perioperative mortality rate varied from 1.6% (1.3e1. Conclusions: The rate of AAA repair in octogenarians as well as EVAR increased over time. Perioperative outcome after intact AAA repair was stable over time, but improved after ruptured repair. Geographical differences in treatment of AAA remain. ª
Introduction
Over the past decade, results of several important randomised controlled trials (RCTs) in treatment of abdominal aortic aneurysms (AAA) have set the ground for dramatic changes in management of this disease.
1e5 Whilst randomised clinical trials are essential for establishing the level I evidence for best medical care provided to patients, analysis of current clinical practice through national or regional databases is a necessary complement to this evidence. Analyses based on registry data have several advantages compared to RCTs. 6 They reflect every-day, often population-based, practice and not just the practice of centres of excellence. They can report on more than 90% of the operated patients, 7 compared to for instance only approximately 20% of the patients that were randomised in the centres participating in the EVAR1 Trial. 1 The results obtained from registries may therefore be more generalisable than results from RCTs. Registry data also give a much faster feedback and thus reflect contemporary as compared to often historical data from the RCTs. Thus, such retrospective analyses of large datasets render a possibility to understand how the results of randomised trials translate to broader medical practice. In addition, audits of this kind can serve as a basis for improvement through comparison.
In vascular surgery, there is a longstanding tradition of registering and analysing results of surgical practice on institutional, regional and national levels. International comparisons of vascular surgical procedures and outcomes have recently been presented through the vascular surgery database reports published by the Vascunet collaboration on behalf of the European Society of Vascular Surgery in 2007 and 2008. 8, 9 The first Vascunet report analysed indications and patient selection for AAA treatment in five countries, while the second report broadened the scope to also include carotid reconstruction and outcome data. Despite discrepancies in data definition and validity of national databases, the reports indicated interesting differences between countries in the treatment of AAA.
The current report, which focuses on AAA, is part of the third analysis of the Vascunet database. Results of the analysis of carotid reconstruction and lower limb revascularization from the Vascunet database will be published separately. The aim of the current analysis is to evaluate indications, treatment strategies and outcome of AAA treatment in nine countries over a contemporary period of five years.
Materials and Methods
Data on primary AAA repairs were amalgamated from nine vascular registries for the period of 2005e2009, Table 1 . The registries operated on a national level in Denmark, Hungary, Italy, Norway, Sweden and the United Kingdom. The registries in Australia and Finland covered hospitals in a specific geographical region, and the Swiss registry included AAA repairs performed at University hospitals and large public hospitals. An estimate of the percentage of AAA repairs performed in each country/region that are included in each registry as well as the presence or absence of internal and external validation procedures for the registries are presented in Table 1 . Data from the full five year period were included from Australia, Denmark, Sweden and United Kingdom, whilst Norway and Switzerland reported data for 2005e2008, Finland and Italy for 2007e2009 and Hungary for 2008e2009. Variables included patient demographics (age, gender), comorbidities (heart, respiratory, and renal disease, hypertension, diabetes, smoking), operative data (date of operation, maximum diameter of the aneurysm, intact or ruptured repair, open or endovascular repair) and outcome data (30-day or in-hospital mortality).
The amalgamated data were analysed overall, per country and per operation year to evaluate national differences in patient demographics, comorbidities, operative data and outcome. Due to the differences in the participating registries, not all data were available from all countries, and there were minor differences in the definitions of the variables. The properties of the participating registries and the provided data are described in detail in Appendix 1. Inhospital or 30-day mortality was used as primary outcome depending on which data were provided in the separate national or regional databases. Co-morbidity data were based on the registered comorbidities as defined in the original databases except for renal disease. For this parameter, five countries presented data on presence of renal disease based on pre-set criteria that varied between registries (Appendix 1). Three countries reported the exact preoperative creatinine level, and in those a creatinine level >150 mmol/l was regarded as presence of renal disease.
To estimate the difference between in-hospital and 30-day mortality, data from the Swedish Vascular Registry (Swedvasc) 2000e2008 was analysed, as this registry included data on hospitalisation dates on most, and date of death for all AAA patients during this period. Date of death is registered with 100% validity due to cross-matching with the population registry. In-hospital as well as 30-day mortality rates were calculated for 63% of AAA patients registered in the Swedvasc registry over this period.
Statistical analysis
All continuous data are presented with mean and 95% confidence intervals. Rates are presented as percentages with 95% confidence intervals (CI). Time trends were analysed with the CochraneArmitage test. Multivariate logistic regression models were used to estimate the odds ratios for various factors in relation to 30-day or in-hospital mortality. For the purpose of this multivariate analysis, only the three comorbidities reported in all countries were included (smoking status, cardiac disease and diabetes). When analysing the effect of treatment country on perioperative mortality, each country was compared to the sum of all other countries in the multivariate analysis. Cases with lacking data were omitted. The models were tested for goodness-of-fit and ability to predict outcome (HosmereLemeshow statistic, C-statistic and Nagelkerkes R-square). Statistical evaluation of data was carried out using R Statistical Software Package (R Foundation for Statistical Computing, Vienna, Austria) and SPSS version 18.0 for Mac (IBM Corporation, Somers, NY, USA).
Results
Overall, data on 40,848 primary AAA repairs were identified ( Table 1 
Intact AAA repair
A total of 31,427 cases were registered as intact AAA repairs. Patient characteristics overall and per country are presented in Table 2 . The mean age at the time of surgery was 72.6 years (72.5e72.7), with a range of 68.3 (67.3e69.3) years in Hungary to 74.6 (74.2e74.9) years in Australia (Table 2) . Of all the intact AAA repairs, 13.3% (12.9e13.7) were performed in women, and one fifth in octogenarians. There was a slight but significant trend towards increasing rate of octogenarians undergoing intact AAA repair over time ( Table 3 ). The use of endovascular aneurysm repair (EVAR) varied between countries, from 14.7% (11.1e19.2) in Finland to 56.0% (53.7e58.2) in Australia (Table 2) . Overall, the rate of endovascular repair increased over the study period (Table 3 ). The rates of octogenarians and EVAR per country and year are presented in Appendices 2 and 3. The rates of comorbidities and mean aneurysm size at repair for the countries (where available) are presented in Table 2 . In Italy, only ranges of aneurysm diameter were registered. Based on an analysis of these data, 70.3% (69.4e71.2) of all intact AAA repairs in Italy were performed in patients with a maximum aneurysm diameter of >5 cm, as compared to 90.3% (89.5e91.0) in the other countries reporting maximum aneurysm size.
The perioperative mortality rates, which were reported as 30-day mortality in some countries and in-hospital mortality in others, for all patients and subgroups are presented in Table 4 . Overall perioperative mortality after intact AAA repair was 2.8% (2.6e3.0). Perioperative mortality was higher in women compared to men, in octogenarians compared to younger patients and after open repair compared to EVAR. (Table 3 ). Perioperative mortality rates per country and year are presented in Appendix 4. The perioperative mortality decreased significantly over time in the United Kingdom (Appendix 4).
In a multivariate logistic regression analysis, increasing age, open repair and presence of comorbidities were all associated with a significantly increased risk for perioperative death, but gender was not ( Table 5 ). Risk of perioperative death was increased in the United Kingdom when compared to all other countries, and decreased in Italy and Norway ( Table 5 ). The goodness-of-fit tests showed acceptable result with respect to the full model ( Table 5 ). The C-statistic (prediction power) of the models were in the range of 0.70e0.71.
Ruptured AAA repair
A total of 7040 cases were registered as ruptured AAA repairs. Patient characteristics overall and per country are presented in Table 2 . Mean patient age, the female to male ratio and octogenarians, as well as mean aneurysm size were higher in patients undergoing repair for ruptured AAA compared to intact AAA repair. A higher rate of the patients were current smokers and had documented renal disease compared to those undergoing intact AAA repair. However, the rate of cardiac disease, hypertension and diabetes was lower. The rate of octogenarians undergoing ruptured AAA repair increased over time, as well as the rate of EVAR for ruptured AAA (Table 3) . Rates of octogenarians and EVAR per country and year are presented in Appendices 2 and 3.
The overall perioperative mortality after ruptured AAA repair was 31.6% (30.6e32.8) (Table 4) , and this decreased over time, p Z 0.004 (Appendix 4). There was no significant change in perioperative mortality over time after open repair (mean 32.6%) or EVAR (mean 19.7%). Perioperative mortalities per country and year are presented in Appendix 4. The perioperative mortality increased over time in Norway and decreased in Sweden and the United Kingdom (Appendix 4). As in intact AAA repair, old age, open repair and presence of comorbidities were associated with perioperative death after ruptured AAA repair in a multivariate logistic regression analysis (Table 5) , but gender or smoking were not. In this multivariate analysis, risk of perioperative death was increased in Denmark and Switzerland when compared to all other countries, and decreased in Italy and Sweden (Table 5 ). The results of the goodness-of-fit tests for the models are presented in Table 5 . The C-statistic (prediction power) of the models were in the range of 0.66e0.67.
30-Day and in-hospital mortality
In-hospital and 30-day mortality rates after AAA repair were analysed in the Swedvasc registry 2000e2008. When analysing 6431 registered intact and ruptured AAA repairs, 718 deaths were registered as in-hospital deaths, out of which 40 occurred more than 30-days after the AAA repair. In total 95 deaths occurred after discharge from the operating hospital but within 30-days from the AAA repair. The overall inhospital mortality rate was 11.2% (10.4e12.0), while the 30-day mortality rate was 11.8% (11.1e12.6). Among patients undergoing intact AAA repair the mortality increased from 2.6 (2.2e3.1) to 3.0% (2.5e3.6), and among patients undergoing ruptured AAA repair the mortality increased from 30.8 (28.8e32.9) to 32.1% (30.1e34.3), when in-hospital and 30-day mortality rates were compared.
Discussion
The Vascunet collaboration makes it possible to amalgamate vascular surgical data across several regions, resulting in large cohorts and enabling geographical comparisons to be made. This current report represents the analysis of the largest international cohort of patients operated on for AAA ever presented. The report confirms ongoing changes in management of AAA disease in Europe and Australia over the past five years, with stable perioperative mortality after intact AAA repair and improved outcome after ruptured repair. In addition, the geographical comparison sheds light on differences in patient selection, operative technique and outcome. Naturally, there are several important limitations associated with the amalgamation of large cohorts of data from different countries. As described in Table 1 , while some data included in the Vascunet analysis have national coverage and include almost all AAA repairs performed in the participating country over the past years, others represent regions or specific hospitals of the participating country, introducing a risk of selection bias. The procedures to assess internal and external validity of data vary between countries. Not all databases could contribute with data for the full 5-year period studied, introducing a risk of bias. To address this, per year analyses for each country are presented in the provided appendices. The definitions and registrations of co-morbidity data vary somewhat, making comparisons of rates of comorbidities complex. There has been a trend, however, towards common definitions, a process that has been facilitated by yearly meetings within the Vascunet collaboration since 1997. The Vascunet group has now defined a data dictionary with specifications for each datafield and each country is moving towards these internationally agreed definitions.
This report is based on retrospective analysis of prospectively gathered data on AAA patients, and thus reflects the current clinical practice where patients are selected to a specific treatment based on clinical features and not randomisation. Thus, comparison of outcomes between different registries based on treatment modality should be interpreted with these limitations in mind. Additionally, the registered outcome endpoint of perioperative mortality varies between countries, with 30-day mortality being registered in some and in-hospital deaths in others. Based on analysis of the Swedvasc registry, although the 30-day mortality rate was slightly higher, there was no significant difference in 30-day and in-hospital mortality rate after AAA repair. In practice, in-hospital mortality rate Interestingly, the current report indicates a large geographical difference in rate of ruptured AAA repair as a percentage of all AAA repairs ( Table 2 ). While only one in ten of AAA repairs are performed for rupture in Italy, almost one-third of all AAA repairs in Finland and Denmark and one quarter of repairs in Sweden are for rupture. These large differences are not explained by potential differences in reporting or database coverage. Factors which affect the rate of repairs for ruptured AAA include diagnostic activity such as screening, patient selection (e.g. diameter limit for treatment, repair on elderly/diseased patients) and rupture rate. One would have suspected that the proportion of patients treated for ruptured AAA would have been lower in scarcely populated countries, but the figures suggest the opposite, indicating that wider indications for elective repair is a more reasonable explanation for low proportions of ruptured AAA repair. The high rate of elective repairs in Italy could be partly explained by the higher rate of small aneurysms (5 cm) being repaired compared to other countries.
Several other factors indicate clear differences in patient selection for AAA repair between countries ( Table 2 ). The proportion of females undergoing AAA repair varies from 8% in Italy to 18% in Sweden. The mean age and rate of octogenarians undergoing AAA repair also vary. More than one quarter of all intact AAA repairs in Australia were performed in octogenarians, as compared to less than one tenth in Hungary. The rate of EVAR was also consistently the highest in Australia throughout the study period (Appendix 3). This could be explained by the higher rate of octogenarians being offered endovascular repair.
The rapid and extensive implementation of EVAR for AAA repair following the positive results of the large randomised trials 1,2 is clearly demonstrated in the current analysis, where the rate of EVAR increased in all countries over time, and reached >50% of all intact AAA repairs in Australia, Italy, Sweden and the United Kingdom in 2009. EVAR for ruptured AAA repair however has not yet been widely adopted, although the rates are increasing over time. The 4.2% improvement in perioperative mortality after ruptured AAA repair over the studied time period could be attributable to the increased use of EVAR for ruptures, as the perioperative mortality for each technique was stable over time but the rate of EVAR for rupture increased by 10%. The perioperative mortality after EVAR for ruptured AAA was on 10e12 However, female gender was not a significant risk factor for perioperative death in a multivariate analysis. The higher age among female patients could explain the higher mortality in this group in the univariate analysis. Importantly, the database does not include any data on the anatomical suitability of the aneurysm for open or endovascular repair. Thus, the difference in outcome after open and endovascular repair is difficult to assess, as this could be partly due to case selection, a higher rate of complex aneurysms being treated with open surgery.
The perioperative mortality rates after intact and ruptured AAA repair in the different countries were more homogenous in the current report than in the previous Vascunet report. 9 The perioperative mortality after intact AAA repair in the United Kingdom has markedly decreased in the current report (4.0%) compared to the previous report (7.9%). 9 This could indicate early success for the AAA quality improvement programme, which was initiated by the Vascular Society of Great Britain and Ireland in order to improve perioperative outcome after the publication of the second Vascunet report. 9 The multivariate analysis, taking some (but not all) important potential confounders related to case-mix into consideration, still indicates a higher risk of perioperative death after intact AAA repair in the UK and a lower risk in Italy and Norway. It should be noted, however, that there has been no external validation of AAA registration in the latter two countries (Table 1) . Additionally, although exact aneurysm size data were not available for all countries, the data suggest that a higher rate of small aneurysms (5 cm) are treated with elective repair in Italy than in other countries. This could have a positive impact on the perioperative outcome in Italy. Interestingly, the patients treated in the UK had the highest reported mean aneurysm diameter, possibly a result of the fact that many centres participated in the UK Small Aneurysm Trial, 13 indicating differences in patient selection that would affect outcome. Patients in the UK also had the highest rate of renal disease, which would affect perioperative outcome negatively. 
